Clinical Edge Journal Scan

Clinical Edge Journal Scan

Impact of anti-CGRP mAb discontinuation and reinitiation in chronic migraine

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Eptinezumab offers effective migraine treatment irrespective of patient baseline characteristics

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Having migraine increases the risk of developing neovascular AMD

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Dietary nutrient patterns may influence the intensity and duration of migraine headaches

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Migraine negatively correlates with large artery atherosclerosis in ischemic stroke

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Caffeine cessation beneficial in episodic migraine

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Atorvastatin plus nortriptyline: A promising combination for migraine therapy

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Rimegepant lowers MMDs and tablet use and improves HRQoL in migraine

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Galcanezumab improves functioning and reduces disability in treatment-resistant migraine

Publish date: February 24, 2022

Read More

Clinical Edge Journal Scan

Clinical Edge Journal Scan Commentary: Migraine February 2022

Author:: Thomas Berk, MD

Publish date: February 2, 2022

Read More

Pages

FULL MENU FULL MENU
More
- MDedge